Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008

upplies

associated with the company's clinical trials and research initiatives,

were $12.6 million, down from $13.9 million in the previous quarter and

up from $7.9 million in the fourth quarter of 2006. The decrease in R&D

expenses between the third and fourth quarters of 2007 is primarily

attributable to an increase in VEC-162 Phase III chronic insomnia

clinical trial costs being offset by a non-recurring third quarter

milestone charge of $5.0 million for the Fiapta(TM) NDA submission in

September 2007. The increase in R&D expenses in the fourth quarter of

2007 relative to the fourth quarter of 2006 is primarily attributable

to the same VEC-162 Phase III chronic insomnia clinical trial that was

initiated in late 2007. For the full year of 2007, total R&D expenses

were $47.2 million, down from $52.1 million in the full year of 2006.

Lower R&D expenses in 2007 resulted from the substantial completion of

the Fiapta(TM) Phase III clinical program in 2006.

General and administrative (G&A) expenses totaled $9.5 million in the

fourth quarter of 2007, down slightly from $9.6 million in the third

quarter of 2007, and up from $4.5 million in the fourth quarter of

2006. The increase in G&A expenses in the fourth quarter of 2007

relative to the fourth quarter of 2006 is primarily due to increased

Fiapta(TM) pre-launch commercial activities, stock-based compensation

charges, salaries and related costs of non-R&D personnel, insurance and

facility expenses. For the full year of 2007, total G&A expenses were

$32.8 million, up from $13.6 million in the prior year. The increase

in G&A expenses is primarily due to increased salaries, benefits and

stock-based compensation expense, increased business and commercial

development expenses, and higher insu
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vion Pharmaceuticals Holds Special Meeting of Stockholders
2. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
3. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
4. Peregrine Pharmaceuticals Doses First Patient in Phase II Clinical Trial of Bavituximab in Patients With Advanced Breast Cancer
5. Peregrine Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
6. Access Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
7. XTL Biopharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
8. Koronis Pharmaceuticals Appoints David Drajeske Director of Business Development
9. Onyx Pharmaceuticals to Present at BIO CEO & Investor Conference
10. Idenix Pharmaceuticals to Present at BIO CEO & Investor Conference
11. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Cambridge Semantics, the leading provider of smart data solutions ... a record-breaking year across the board for the company. ... Platform and our Smart Data solutions, our customers were able ... led to record growth for the company in 2014,” said ...
(Date:1/22/2015)... San Diego, California (PRWEB) January 22, 2015 ... R Promotional Offer to their comprehensive portfolio of ... Offer allows customers to purchase a Centrifuge 5424/5424 R ... Pipette Bundle of either Eppendorf Research plus or Eppendorf ...
(Date:1/22/2015)... Selexis SA, a serial innovation company with ... used for drug discovery to commercial manufacturing, announced today ... Next-Generation Sequencing (NGS) data packages. The NGS analysis ... ensuring the integrity of the gene, validation of the ...
(Date:1/22/2015)... Jan. 22. 2015  Varian Medical Systems (NYSE: VAR ... honored for its commitment to sustainability with inclusion on a ... the highest ranked healthcare equipment company among the Corporate Knights ... World Economic Forum at Davos, Switzerland . ...
Breaking Biology Technology:Cambridge Semantics Announces Record Results for 2014 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2
... to $160 million or more, up from $42 ... - First HGS product sales expected with delivery of ABthrax(TM) to ... - First Albuferon(R) Phase 3 data expected late 2008 -, - Enrollment ... ...
... Local Efforts To Improve Diabetes Care, PERRYSBURG, ... to improve the medical, humanistic and financial elements ... Business Coalition on,Health (NBCH). FrontPath Health Coalition, through ... Perrysburg, Ohio, will lead this,community-wide effort that includes ...
... YORK, Feb. 25 Care to Care, a specialty ... signed,Touchstone Health HMO Inc. as a client. As a ... has grown to over 700,000,lives., (Logo: http://www.newscom.com/cgi-bin/prnh/20080225/NYM113LOGO ... flattered to be selected as the Radiology,Benefit Manager for ...
Cached Biology Technology:Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 2Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 3Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 4Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 5Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 6Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 7Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 8Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 9Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 10Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 11FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 2FrontPath Health Coalition To Lead Community-wide Group in Pilot Program 3Care to Care Begins Providing Radiology Benefit Management Services to Touchstone Health 2
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
(Date:1/22/2015)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) a biometric ... recent success of the Wocket™ smart wallet at CES 2015 in ... named as one of the "11 Hot Products at CES" in a ... CES So Far" by Newseveryday.com and "The top 10 gadgets from CES ...
(Date:1/22/2015)... 2015   EyeLock, Inc. , a market leader of iris-based ... Gerber to the new role of Senior Vice President ... development of mobile platforms and wearable solutions for EyeLock,s technologies. ... in the semiconductor industry to his role at EyeLock, with ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2
... scientific conference devoted primarily to osteoporosis, will open on ... on four key topics in nutrition and bone health. ... Epidemiology Resource Centre at the University of Southampton; and ... of Oxford, will speak on the developmental origins of ...
... whose moist permeable skins make them susceptible to slight ... impending alterations in biodiversity during rapid climate change. ... predictive power of this sensitive group of animals in ... birds. The study appears this week in the advance ...
... schizophrenia, major depression and cancer are not caused ... A novel computational biology method developed by a ... http://www.njit.edu/news/2008/2008-367.php , associate professor in NJIT,s department of ... to uncover the critical genes responsible for disease ...
Cached Biology News:Nutrition and bone health session to open the IOF World Congress on Osteoporosis in Bangkok 2Study confirms amphibians' ability to predict changes in biodiversity 2NJIT professor finds engineering technique to identify disease-causing genes 2
Request Info...
DNA polymerase I, large fragment...
supplied with 10x reaction buffer...
... from yeast/leuconostoc overproducer ATP: ... EC 2.7.1.1/1.1.1.49. One unit of ... of D-glucose in 1 min ... One unit of G6P-DH will ...
Biology Products: